Hospices Civils de Lyon: Ovarian Neoplasms trials

The registry lists 11 Ovarian Neoplasms studies with Hospices Civils de Lyon as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 2Phase 4 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian CancerRecruitingNCT06572735
• Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian CancerRecruitingNCT04811703Phase 1
• PROADAPT-ovary/EWOC-2RecruitingNCT04284969Not applicable
• Low Grade Serous Ovarian Carcinoma and Uterine Involvement : Should Hysterectomy be the RuleCompletedNCT05741554
• Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture)CompletedNCT05472532Not applicable
• NIRAPK : Study of the Relationship(s) Between Clinical, Biological and Pharmacokinetic Metrics and Toxicities When Niraparib is Used as Maintenance Treatment for Ovarian Cancer Patients.TerminatedNCT04861181Phase 4
• Impact of the COVID-19 Pandemic in Gynecological OncologyCompletedNCT04351139
• Optical Biopsy in Gynecological SurgeryCompletedNCT04154683Not applicable
• Tolerance of Intraperitoneal (IP) Nivolumab After Extensive Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Ovarian CarcinomaCompletedNCT03959761Phase 1/2
• Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian Cancer (Cyto-chip 2)CompletedNCT03931304
• EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian CancerCompletedNCT02001272Phase 2